Immuno-Biological Laboratories Co., Ltd (IBL) was established in 1982 as a company dedicated to research and development. The antibodies IBL created are widely used around the world by pharmaceutical firms, universities, and laboratories in hospitals and testing centers.
IBL's core businesses are in the fields of both research and medicine. IBL research, develop, manufacture and supply various immunological research reagents, such as ELISA kits, antibodies, cell culture-related products, and customized services. They also conduct research and development on the materials used in diagnostic products and valuable seeds in their existing portfolio, and aim to obtain approval for their use in in-vitro diagnostic products and drugs.
Visit site: https://www.ibl-japan.co.jp/en/